SCHEMBL2252467

SCHEMBL2252467

O=C(O)c1ccc(-c2ccc(F)cc2)cc1/C=C/Cc1cccc2ccc(O)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.51
▸ BAD Q92934 1/20 0.51
▸ PTPN1 P18031 4/20 0.38
▸ MTNR1A P48039 1/20 0.38
▸ MTNR1B P49286 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NQO2 P16083 1/20 0.38
▸ MCL1 Q07820 1/20 0.37
▸ DCLRE1B Q9H816 1/20 0.37
▸ FDPS P14324 1/20 0.37
▸ RELA Q04206 1/20 0.36
▸ PTGER1 P34995 1/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ PTGER3 P43115 1/20 0.36
▸ PTGER2 P43116 1/20 0.36
▸ DHODH Q02127 2/20 0.35
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ CYP1B1 Q16678 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2252475 1.00 BCL2L1 (0.51) BCL2L1BADPTPN1MTNR1AMTNR1B
SCHEMBL2254708 0.90 BCL2L1 (0.49) BCL2L1BADPTPN1MTNR1AMTNR1B
SCHEMBL2254705 0.90 BCL2L1 (0.49) BCL2L1BADPTPN1MTNR1AMTNR1B
SCHEMBL2257798 0.85 BCL2L1 (0.60) BCL2L1BADPTPN1MEN1KMT2A
SCHEMBL2257799 0.85 BCL2L1 (0.60) BCL2L1BADPTPN1MEN1KMT2A
SCHEMBL2253099 0.82 BCL2L1 (0.49) BCL2L1BADMEN1KMT2AMCL1
SCHEMBL2253096 0.82 BCL2L1 (0.49) BCL2L1BADMEN1KMT2AMCL1
SCHEMBL2256052 0.82 BCL2L1 (0.51) BCL2L1BADMEN1KMT2AMCL1
SCHEMBL2256047 0.82 BCL2L1 (0.51) BCL2L1BADMEN1KMT2AMCL1
SCHEMBL2254605 0.81 BCL2L1 (0.49) BCL2L1BADESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 — — EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 — — US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 — — US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 — — US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885PTPN1 3895/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885PTPN1 3895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback